Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina H Chung

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
PNAS Nexus|August 26, 2022
A flux-based machine learning model to simulate the impact of pathogen metabolic heterogeneity on drug interactionsCarolina H Chung, Sriram Chandrasekaran
Drug Discovery Today|April 10, 2022
Machine learning to design antimicrobial combination therapies: Promises and pitfallsJennifer M Cantrell, Carolina H Chung, Sriram Chandrasekaran
Metabolites|September 26, 2021
Next-Generation Genome-Scale Metabolic Modeling through Integration of Regulatory MechanismsCarolina H Chung, Da-Wei Lin, Alec Eames, et al.
Trends in Pharmacological Sciences|March 12, 2026
Targeting metabolism to combat anticancer and antibacterial drug resistanceCarolina H Chung, Rupa Bhowmick, Annie J Badenoch, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
Modeling Microbiome Modulation of Tumor Metabolic Networks to Predict Synergistic TherapiesAnnie J Badenoch, Zeyang Pang, Carolina H Chung, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Transfer learning predicts species-specific drug interactions in emerging pathogensCarolina H Chung, David C Chang, Nicole M Rhoads, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Reprogramming SREBP1-dependent lipogenesis and inflammation in high-risk breast with licochalcone A: a novel path to cancer preventionAtieh Hajirahimkhan, Elizabeth T Bartom, Carolina H Chung, et al.
Cell Reports Methods|July 7, 2026
TACTIC: A transfer learning framework to predict drug interactions in emerging pathogensCarolina H Chung, David C Chang, Nicole M Rhoads, et al.
International Journal of Cancer|November 28, 2025
Reprogramming SREBP1-dependent lipogenesis and inflammation in high-risk breast with licochalcone A: A novel path to cancer preventionAtieh Hajirahimkhan, Elizabeth T Bartom, Carolina H Chung, et al.
NPJ Breast Cancer|March 14, 2023
Author Correction: Lipid exposure activates gene expression changes associated with estrogen receptor negative breast cancerShivangi Yadav, Ranya Virk, Carolina H Chung, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
PNAS Nexus|August 26, 2022
A flux-based machine learning model to simulate the impact of pathogen metabolic heterogeneity on drug interactionsCarolina H Chung, Sriram Chandrasekaran
Drug Discovery Today|April 10, 2022
Machine learning to design antimicrobial combination therapies: Promises and pitfallsJennifer M Cantrell, Carolina H Chung, Sriram Chandrasekaran
Metabolites|September 26, 2021
Next-Generation Genome-Scale Metabolic Modeling through Integration of Regulatory MechanismsCarolina H Chung, Da-Wei Lin, Alec Eames, et al.
Trends in Pharmacological Sciences|March 12, 2026
Targeting metabolism to combat anticancer and antibacterial drug resistanceCarolina H Chung, Rupa Bhowmick, Annie J Badenoch, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
Modeling Microbiome Modulation of Tumor Metabolic Networks to Predict Synergistic TherapiesAnnie J Badenoch, Zeyang Pang, Carolina H Chung, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Transfer learning predicts species-specific drug interactions in emerging pathogensCarolina H Chung, David C Chang, Nicole M Rhoads, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Reprogramming SREBP1-dependent lipogenesis and inflammation in high-risk breast with licochalcone A: a novel path to cancer preventionAtieh Hajirahimkhan, Elizabeth T Bartom, Carolina H Chung, et al.
Cell Reports Methods|July 7, 2026
TACTIC: A transfer learning framework to predict drug interactions in emerging pathogensCarolina H Chung, David C Chang, Nicole M Rhoads, et al.
International Journal of Cancer|November 28, 2025
Reprogramming SREBP1-dependent lipogenesis and inflammation in high-risk breast with licochalcone A: A novel path to cancer preventionAtieh Hajirahimkhan, Elizabeth T Bartom, Carolina H Chung, et al.
NPJ Breast Cancer|March 14, 2023
Author Correction: Lipid exposure activates gene expression changes associated with estrogen receptor negative breast cancerShivangi Yadav, Ranya Virk, Carolina H Chung, et al.
Pageof 2